ACHV

2.36

1.67% -0.04

Handel nachbörslich: 2.47 0.11 +4.66%

Achieve Life Sciences Inc (ACHV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACHV? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.40

Offen:

$2.39

24-Stunden-Volumen:

262.01K

Relative Volume:

1.25

Marktkapitalisierung:

$78.04M

Einnahmen:

Nettoeinkommen (Verlust:

$-32.94M

KGV:

-2.1261

EPS:

-1.11

Netto-Cashflow:

$-24.95M

1W Leistung:

+18.59%

1M Leistung:

-17.48%

6M Leistung:

-49.89%

1J Leistung:

-48.42%

1-Tages-Spanne:

$2.36

$2.48

1-Wochen-Bereich:

$1.96

$2.63

52-Wochen-Spanne:

$1.84

$5.59

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Firmenname

Achieve Life Sciences Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (677)

Telefon

425-686-1500

Adresse

22722 29TH DR. SE, SEATTLE, BC

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-11

Neueste SEC-Einreichungen

ACHV's Discussions on Twitter

Vergleichen Sie ACHV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ACHV Achieve Life Sciences Inc	2.36	78.04M	0	-32.94M	-24.95M	-1.11
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-14	Eingeleitet	Rodman & Renshaw	Buy
2024-09-27	Eingeleitet	Raymond James	Strong Buy
2023-05-10	Bestätigt	Maxim Group	Buy
2021-06-23	Eingeleitet	Oppenheimer	Outperform

Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 23, 2025

Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) - MSN

Apr 23, 2025

LPL Financial LLC Has $693,000 Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Apr 23, 2025

Apr 22, 2025

Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial - Yahoo Finance

Apr 22, 2025

Apr 21, 2025

Cytisinicline shows promise for smoking cessation By Investing.com - Investing.com South Africa

Apr 21, 2025

Achieve Life Sciences Expects to File New Drug Application in US for Smoking Cessation Medication - marketscreener.com

Apr 21, 2025

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine | ACHV Stock News - GuruFocus

Apr 21, 2025

Achieve Life Sciences (ACHV) Confirms Cytisinicline Efficacy in Phase 3 ORCA-3 Trial | ACHV Stock News - GuruFocus

Apr 21, 2025

Cytisinicline’s FDA Path Ignites ACHV Stock: Could This Biotech Gem Soar on Smoking and Vaping Cessation Breakthroughs? - Own Snap

Apr 21, 2025

Achieve Life Sciences Announces Cytisinicline Phase 3 - GlobeNewswire

Apr 21, 2025

Breakthrough Smoking Cessation Drug Outperforms Existing Treatments in Major Phase 3 Trial, JAMA Reports - Stock Titan

Apr 21, 2025

Apr 12, 2025

157,519 Shares in Achieve Life Sciences, Inc. (NASDAQ:ACHV) Purchased by Raymond James Financial Inc. - MarketBeat

Apr 12, 2025

Apr 08, 2025

Raymond James Financial Inc. Invests $554,000 in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

Apr 08, 2025

Apr 01, 2025

ACHV Stock Touches 52-Week Low at $2.5 Amid Market Challenges - Investing.com UK

Apr 01, 2025

Mar 31, 2025

ACHIEVE LIFE SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus

Mar 31, 2025

Mar 24, 2025

Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Mar 24, 2025

Mar 23, 2025

Achieve Life Sciences (ACHV) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Mar 23, 2025

Mar 21, 2025

Insider Buying: Mark Oki Acquires Shares of Achieve Life Sciences Inc (ACHV) - GuruFocus

Mar 21, 2025

Mar 20, 2025